• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防性卵巢切除术后的乳头状腹膜癌病

Papillary peritoneal carcinomatosis after prophylactic oophorectomy.

作者信息

Kemp G M, Hsiu J G, Andrews M C

机构信息

Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia 23507.

出版信息

Gynecol Oncol. 1992 Dec;47(3):395-7. doi: 10.1016/0090-8258(92)90147-b.

DOI:10.1016/0090-8258(92)90147-b
PMID:1473756
Abstract

Prophylactic oophorectomy has been recommended in patients with a strongly positive family history for ovarian carcinoma. A patient with a strongly positive family history underwent a prophylactic oophorectomy and, 5 years later, developed a primary peritoneal papillary serous adenocarcinoma. A prophylactic oophorectomy does not afford complete protection in some patients with familial ovarian cancer syndrome. Any tissue derived from the coelomic epithelium may potentially undergo multifocal malignant transformation.

摘要

对于有卵巢癌家族史呈强阳性的患者,建议进行预防性卵巢切除术。一名有卵巢癌家族史呈强阳性的患者接受了预防性卵巢切除术,5年后发生了原发性腹膜乳头状浆液性腺癌。预防性卵巢切除术并不能为某些患有家族性卵巢癌综合征的患者提供完全的保护。任何来源于体腔上皮的组织都有可能发生多灶性恶性转化。

相似文献

1
Papillary peritoneal carcinomatosis after prophylactic oophorectomy.预防性卵巢切除术后的乳头状腹膜癌病
Gynecol Oncol. 1992 Dec;47(3):395-7. doi: 10.1016/0090-8258(92)90147-b.
2
Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.有卵巢癌家族史的女性在预防性卵巢切除术后发生原发性腹膜癌。吉尔达·拉德纳家族性卵巢癌登记处报告。
Cancer. 1993 May 1;71(9):2751-5. doi: 10.1002/1097-0142(19930501)71:9<2751::aid-cncr2820710911>3.0.co;2-j.
3
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.BRCA1或BRCA2基因突变携带者的预防性卵巢切除术。
N Engl J Med. 2002 May 23;346(21):1616-22. doi: 10.1056/NEJMoa012158. Epub 2002 May 20.
4
Serous carcinoma of the peritoneum after oophorectomy.卵巢切除术后腹膜浆液性癌
Obstet Gynecol. 1992 Sep;80(3 Pt 2):558-60.
5
Familial peritoneal ovarian carcinomatosis: a new clinical entity?家族性腹膜卵巢癌:一种新的临床实体?
Med Hypotheses. 1986 Oct;21(2):171-7. doi: 10.1016/0306-9877(86)90007-1.
6
Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome.家族性卵巢癌综合征患者预防性卵巢切除术后的腹膜癌转移
Obstet Gynecol. 1985 Sep;66(3 Suppl):93S-94S.
7
Papillary intraperitoneal neoplasia resembling ovarian carcinoma after removal of benign ovaries.良性卵巢切除术后出现的类似卵巢癌的乳头状腹膜内瘤变。
W V Med J. 1993 Jul;89(7):282-3.
8
A diagnostic dilemma following risk-reducing surgery for BRCA1 mutation - a case report of primary papillary serous carcinoma presenting as sigmoid cancer.BRCA1基因突变风险降低手术后的诊断困境——一例表现为乙状结肠癌的原发性乳头状浆液性癌病例报告
World J Surg Oncol. 2007 Sep 12;5:102. doi: 10.1186/1477-7819-5-102.
9
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.与BRCA1和BRCA2基因突变相关的遗传性乳腺癌卵巢癌综合征家族中女性接受预防性卵巢切除术后的腹腔内癌转移
Gynecol Oncol. 2005 May;97(2):457-67. doi: 10.1016/j.ygyno.2005.01.039.
10
Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case.家族性宫颈、腹膜和卵巢乳头状浆液性癌:首例病例报告。
Gynecol Oncol. 1998 Aug;70(2):289-94. doi: 10.1006/gyno.1998.5046.

引用本文的文献

1
Surgically Induced Menopause-A Practical Review of Literature.手术性绝经:文献综述的实用分析
Medicina (Kaunas). 2019 Aug 14;55(8):482. doi: 10.3390/medicina55080482.
2
Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.具有遗传易感性的女性腹膜癌:对犹太人群的影响。
Fam Cancer. 2004;3(3-4):265-81. doi: 10.1007/s10689-004-9554-y.
3
Prophylactic oophorectomy in Ontario.安大略省的预防性卵巢切除术。
Fam Cancer. 2001;1(3-4):143-8. doi: 10.1023/a:1021174604905.
4
Prophylactic surgery and other strategies for reducing the risk of familial ovarian cancer.
Curr Treat Options Oncol. 2003 Apr;4(2):105-10. doi: 10.1007/s11864-003-0011-1.